Thyroid Medication Recall Elevated to Highest Warning Level: FDA
NEED TO KNOW The FDA has elevated the recall of a thyroid medication to Class I, due to…
Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02
Designation is driven by compelling Phase 2 clinical data in patients with complicated Staphylococcus aureus bacteremia showing AP-SA02…
Goldman picks China healthcare stocks for a post-AI trade
Chinese corporate earnings are on a tear, giving investors clues on which stock sectors offer untapped returns, according…
IonQ Advances Quantum Computing With Superion 256: What’s Ahead?
IonQ IONQ has launched Superion 256, its sixth-generation quantum computing platform and the foundation for future compute products.…
Wall Street week ahead: The market focuses on key inflation updates
NEW YORK (AP) — Wall Street will get several important updates about inflation this week. On Thursday, the…
Capricor (CAPR) Closed 58% Higher on an FDA Lifeline. Is Approval Really Back on Track?
Capricor Therapeutics, Inc. (NASDAQ:CAPR) closed 58% higher at $6.65 on August 14 after the company said the FDA…
FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
NRx Pharmaceuticals, Inc. FDA identified no major deficiencies related to the ketamine drug product, ingredients, proposed labeling, CMC,…
Northwest Biotherapeutics Announces MOU for Collaboration With the Saudi Pharmaceutical Industries and Medical Appliance Company
SPIMACO is One of the Largest Saudi Pharma Companies and a Leader in 21 Markets Across the MENA…
Court orders Meta to pay $567 million to address kids’ mental health, safety on its platforms
A New Mexico court has ordered Instagram and Facebook parent company Meta to pay $567 million to address…
DiCaprio and Bezos launch $200M fund for endangered species
LOS ANGELES (AP) — Foundations funded and co-founded by Leonardo DiCaprio and Jeff Bezos have launched an initiative…
Revolution Medicines’ New Drug Application for Daraxonrasib Accepted for Review by U.S. FDA for Previously Treated Metastatic Pancreatic Cancer
Revolution Medicines, Inc. REDWOOD CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
Spectrum Dynamics Medical Ignites New Era in Digital SPECT/CT with All-Energy Enhancement to FDA-Cleared, CE-Marked VERITON-CT 400 Series
Groundbreaking product improvement brings innovative end-to-end detection and processing platform while maintaining the simplicity of a single collimator…